Has Joyce Liu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,345,050 in general payments to Joyce Liu, MD across 365 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joyce Liu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joyce Liu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joyce Liu, MD

Internal Medicine · Charlestown, MANPI 1144395179

Payments from drug & device makers

$10,345,050in general payments, 2019–2025

Across 365 payments — averaging $28,343 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron$2.7M
Tesaro, Inc.$2.7M
Merck$1.3M
AstraZeneca$1M
Pfizer$980K
Astrazeneca UK Limited$584K
plus $1.1M from 15 others

$6,074in research payments, 2019–2025

Across 22 payments — averaging $276.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$5K
Pfizer$940

What the payments were for

Consulting fees$96,61374%
Speaking & faculty fees$3,1742%
Grants$7931%
Travel & lodging$27,17321%
Food & beverage$2,1352%
Education$430%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron	110	$2,688,389
Tesaro, Inc.	44	$2,670,788
Merck	17	$1,339,555
AstraZeneca	34	$1,027,902
Pfizer	26	$980,202
Astrazeneca UK Limited	13	$584,442
GSK	63	$489,859
Clovis Oncology, Inc.	11	$456,761
Genentech, Inc.	3	$52,700
Daiichi Sankyo Inc.	11	$24,215
AbbVie	11	$12,184
E.r. Squibb & Sons, L.L.C.	6	$5,775
Eisai Inc.	3	$4,119
F. Hoffmann-la Roche AG	1	$2,965
Genmab U.S., Inc.	2	$1,600
Eli Lilly	1	$1,600
Genentech USA, Inc.	2	$1,590
Taiho Oncology, Inc.	2	$155
Jazz Pharmaceuticals Inc.	1	$147
Deciphera Pharmaceuticals Inc.	2	$66
Tanabe Pharma America, Inc.	2	$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LYNPARZA$8,905
TECENTRIQ$6,205
LENVIMA$4,055
Elahere$3,600
Avastin$3,240
Enhertu$2,055
Lucitanib$2,014
EPKINLY$1,600
ZEJULA$1,375
KEYTRUDA$886
OPDIVO$643

How this compares

$10,345,050 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$33,968

Medicare patients

Services billed

267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Charlestown

Noopur RajeBoston$19.9M
Michael McCartneyNewburyport$17.6M
Rebecca HeistBoston$17.4M
Richard PlattBoston$13.5M
Ryan CorcoranBoston$11.4M
Elizabeth LeeBoston$9.8M
Adnan DahdulSpringfield$8.8M
Ryan SullivanCambridge$8.5M
Xiuning leBoston$7.9M
Adrienne WaksBoston$7.3M

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →